Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2076
Columbia Financial
CLBK
$1.22B
| $214K | ﹤0.01% |
13,745
| – | – |
|
2077
Ardmore Shipping
ASC
$752M
| $213K | ﹤0.01% |
65,047
-72,856
| -53% | -$232K |
|
2078
Red Violet
RDVT
$1.14B
| $213K | ﹤0.01% |
+8,174
| New | +$194K |
|
2079
Federal Realty Investment Trust
FRT
$10.2B
| $212K | ﹤0.01% |
2,535
-4,395
| -63% | -$366K |
|
2080
Expro Ltd
XPRO
$1.98B
| $212K | ﹤0.01% |
12,870
-3,858
| -23% | -$50.4K |
|
2081
ATI
ATI
$27.8B
| $210K | ﹤0.01% |
12,549
-600,784
| -98% | -$7.63M |
|
|
DNB
2082
DELISTED
Dun & Bradstreet
DNB
| $209K | ﹤0.01% |
+8,397
| New | +$224K |
|
2083
SI-BONE Inc
SIBN
$894M
| $208K | ﹤0.01% |
+6,963
| New | +$170K |
|
|
NESR
2084
National Energy Services Reunited Corp
NESR
$3.28B
| $207K | ﹤0.01% |
+20,821
| New | +$173K |
|
2085
RCI Hospitality Holdings
RICK
$237M
| $206K | ﹤0.01% |
5,218
-19,344
| -79% | -$534K |
|
2086
Dianthus Therapeutics
DNTH
$6.14B
| $205K | ﹤0.01% |
1,635
-148
| -8% | -$16.8K |
|
|
PRTK
2087
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $204K | ﹤0.01% |
32,626
+1,630
| +5% | +$9.59K |
|
|
LUNA
2088
DELISTED
Luna Innovations Incorporated
LUNA
| $204K | ﹤0.01% |
20,643
-13,127
| -39% | -$105K |
|
2089
Matsons
MATX
$6.64B
| $202K | ﹤0.01% |
+3,540
| New | +$193K |
|
|
VVNT
2090
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $202K | ﹤0.01% |
+9,734
| New | +$194K |
|
2091
Pitney Bowes
PBI
$2.27B
| $200K | ﹤0.01% |
32,423
+19,065
| +143% | +$115K |
|
2092
AXT Inc
AXTI
$4.22B
| $198K | ﹤0.01% |
20,648
+7,949
| +63% | +$63.8K |
|
|
WBT
2093
DELISTED
Welbilt, Inc.
WBT
| $197K | ﹤0.01% |
+14,938
| New | +$134K |
|
|
XHR
2094
Xenia Hotels & Resorts
XHR
$1.81B
| $193K | ﹤0.01% |
12,688
-23,380
| -65% | -$280K |
|
2095
Cyclerion Therapeutics
CYCN
$19.6M
| $191K | ﹤0.01% |
+3,113
| New | +$212K |
|
|
FLNA
2096
Filana Therapeutics
FLNA
$45.5M
| $190K | ﹤0.01% |
27,897
-32,473
| -54% | -$290K |
|
|
MRNS
2097
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $188K | ﹤0.01% |
+15,436
| New | +$215K |
|
2098
Immersion
IMMR
$252M
| $185K | ﹤0.01% |
16,362
-972
| -6% | -$7.71K |
|
|
FMBI
2099
DELISTED
First Midwest Bancorp Inc/IL
FMBI
| $183K | ﹤0.01% |
11,495
| – | – |
|
|
DRRX
2100
DELISTED
DURECT Corp
DRRX
| $180K | ﹤0.01% |
8,719
-32,360
| -79% | -$615K |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.